Systematic Financial Management LP Has $42.66 Million Stock Position in Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

Systematic Financial Management LP increased its stake in shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA - Free Report) by 9.2% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 2,292,473 shares of the real estate investment trust's stock after acquiring an additional 192,273 shares during the period. Sabra Health Care REIT accounts for about 1.1% of Systematic Financial Management LP's holdings, making the stock its 15th largest position. Systematic Financial Management LP owned about 0.97% of Sabra Health Care REIT worth $42,663,000 as of its most recent filing with the SEC.

Other institutional investors have also made changes to their positions in the company. Price T Rowe Associates Inc. MD boosted its stake in Sabra Health Care REIT by 7.5% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 122,630 shares of the real estate investment trust's stock valued at $1,812,000 after purchasing an additional 8,554 shares during the period. Cetera Investment Advisers grew its stake in shares of Sabra Health Care REIT by 34.1% in the first quarter. Cetera Investment Advisers now owns 406,675 shares of the real estate investment trust's stock worth $6,007,000 after acquiring an additional 103,413 shares during the last quarter. GAMMA Investing LLC increased its position in Sabra Health Care REIT by 40.0% during the second quarter. GAMMA Investing LLC now owns 3,682 shares of the real estate investment trust's stock worth $57,000 after acquiring an additional 1,052 shares during the period. Accel Wealth Management bought a new stake in Sabra Health Care REIT in the 2nd quarter valued at $185,000. Finally, Gilman Hill Asset Management LLC grew its position in Sabra Health Care REIT by 1.5% in the 2nd quarter. Gilman Hill Asset Management LLC now owns 621,173 shares of the real estate investment trust's stock worth $9,566,000 after purchasing an additional 9,318 shares during the last quarter. 99.40% of the stock is owned by institutional investors.

Sabra Health Care REIT Price Performance

Shares of Sabra Health Care REIT stock traded down $0.21 during mid-day trading on Thursday, reaching $18.22. 813,970 shares of the stock were exchanged, compared to its average volume of 2,033,527. The company has a market cap of $4.31 billion, a price-to-earnings ratio of 44.95, a price-to-earnings-growth ratio of 2.32 and a beta of 1.24. Sabra Health Care REIT, Inc. has a fifty-two week low of $12.83 and a fifty-two week high of $20.03. The company has a current ratio of 4.16, a quick ratio of 4.16 and a debt-to-equity ratio of 0.90. The firm has a 50-day simple moving average of $18.61 and a 200 day simple moving average of $16.92.

Sabra Health Care REIT (NASDAQ:SBRA - Get Free Report) last issued its quarterly earnings data on Thursday, October 31st. The real estate investment trust reported $0.13 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.35 by ($0.22). Sabra Health Care REIT had a net margin of 14.20% and a return on equity of 3.51%. The business had revenue of $178.00 million during the quarter, compared to the consensus estimate of $177.19 million. During the same quarter in the previous year, the firm posted $0.34 EPS. On average, sell-side analysts predict that Sabra Health Care REIT, Inc. will post 1.39 EPS for the current fiscal year.

Sabra Health Care REIT Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, November 29th. Shareholders of record on Friday, November 15th were paid a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.59%. The ex-dividend date was Friday, November 15th. Sabra Health Care REIT's dividend payout ratio is presently 292.69%.

Wall Street Analyst Weigh In

SBRA has been the subject of several research reports. Citigroup upgraded shares of Sabra Health Care REIT from a "neutral" rating to a "buy" rating and increased their target price for the company from $17.00 to $20.00 in a research note on Friday, September 13th. Mizuho reissued a "neutral" rating and set a $20.00 price objective on shares of Sabra Health Care REIT in a report on Thursday. Wells Fargo & Company upgraded Sabra Health Care REIT from an "equal weight" rating to an "overweight" rating and upped their target price for the company from $16.00 to $20.00 in a research note on Tuesday, October 1st. Scotiabank lifted their price target on shares of Sabra Health Care REIT from $17.00 to $18.00 and gave the stock a "sector perform" rating in a research note on Friday, October 11th. Finally, Truist Financial increased their price objective on shares of Sabra Health Care REIT from $16.00 to $18.00 and gave the company a "buy" rating in a research note on Wednesday, September 4th. Two investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $19.14.

Sabra Health Care REIT Profile

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing - Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing - Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.